targeted therapy in cll in 2022 and in the future
Published 2 years ago • 1.5K plays • Length 1:50Download video MP4
Download video MP3
Similar videos
-
1:19
telomerase inhibition as a novel targeted therapy for myelofibrosis
-
1:00
the future of cll treatment: chemotherapy and targeted inhibitors
-
2:31
the role of chemoimmunotherapy in the era of targeted therapies for cll
-
1:33
future advancements in the treatment of cll
-
4:57
sequencing of targeted therapies for cll
-
1:29
how targeted therapies are sequenced in cll
-
2:05
the latest on targeted therapies in cll
-
1:48
an analysis of transfusion-related cost offsets & time burden in pts with mf in the momentum trial
-
1:53
clinical outcomes of btki ven treatment in cll/sll: double-exposed vs double-refractory patients
-
1:15
exciting updates in cll and the importance of immune characterization
-
1:20
mechanisms of resistance to targeted therapies in cll
-
3:35
an insight into time-limited therapy in cll
-
8:57
outcomes of sct in t-all and t-lbl
-
1:04
the future of cll therapy
-
0:40
from chemotherapy towards targeted therapies in cll
-
1:28
the future of cll treatment
-
1:20
the progress of cll research: towards targeted therapy
-
0:56
the current treatment landscape in cll
-
1:15
the promise of targeted combination therapies in cll & their impact on immune function